This Multi-Product Plant (MPP) is a primary production facility to manufacture active pharmaceutical ingredients for new Schering-Plough products including Zetia®, a cholesterol absorption inhibitor. This facility is the key commercial bulk production site for this compound for the worldwide market. Faithful+Gould was appointed for two multi-product plants, in 2000 and 2002 - MPP1 and MPP2 respectively, as project controls consultants, to provide fully integrated project controls services.
The Approach: Project controls, cost management, scheduling, estimate validation, risk analysis, project support services. The scope of work was let to a single main contractor on an EPCmV basis. Outcome: The projects were successfully completed on time and within budget, MPP1 was the first project that Faithful+Gould had undertaken with Schering-Plough in Singapore, we were then appointed for the second expansion phase (MPP2) and the rest of Schering-Plough's major capital investment projects in Singapore.